COMMISSION IMPLEMENTING REGUL ATION (EU) 2021/51 
of 22 Januar y 2021 
author ising a change of the conditions of use of the novel food ‘trans-resv eratrol’ under Regulation 
(EU) 2015/2283 of the European Parliament and of the Council and amending Commission 
Implementing Regulation (EU) 2017/2470 
(Text with EEA relevance) 
THE EUR OPEAN COMMISSION, 
Havi ng regar d to the Treaty on the Functioning of the European Union, 
Havi ng regar d to Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on 
novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing 
Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) 
No 1852/2001 (1), and in particular Article 12 thereof, 
Whereas: 
(1) Regulation (EU) 2015/2283 provides that only novel foods author ised and included in the Union list may be placed 
on the mark et within the Union. 
(2) Pursuant to Article 8 of Regulation (EU) 2015/2283, Commission Imple menting Regulation (EU) 2017/2470 (2) 
establishing a Union list of author ised novel foods was adopt ed. 
(3) Commission Implementing Decision (EU) 2016/1190 (3) author ised the placing on the Union mark et of trans- 
resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the 
Council (4), to be used in food supplements as defined in Directive 2002/46/EC of the European Parliament and of 
the Council (5), in capsule or tablet form, for the adult population. 
(4) On 31 Januar y 2020, the compan y DSM Nutr itional Products Europe (‘the applicant ’) submitted an application to 
the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to change the conditions of use of 
the novel food ‘trans-resveratrol’. The applicant requeste d the modific ation of the deliver y formats for food 
supplements containing the novel food trans-resveratrol, in particular removi ng the specifi c deliver y formats, 
capsule or tablet form, as the only allowe d forms of the food supplements as listed in the Union list. 
(5) The applicant considers that the modification of the deliver y formats for food supplements containing trans- 
resveratrol is necessar y, as it would allow trans-resveratrol to be used in other food supplement forms than capsules 
or tablets. 
(6) There are a number of novel foods currently author ised in food supplements and listed in the Union list of novel 
foods for which the deliver y formats have not been specified. Theref ore, the modifi cation of the deliver y formats for 
food supplements containing trans-resveratrol would ensure consistency regarding the conditions of use of food 
supplements, as well as provid e more options to food business operat ors to follow consumer preferences. 
(1)OJ L 327, 11.12.2015, p. 1. 
(2)Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance 
with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (OJ L 351, 30.12.2017, p. 72). 
(3)Commission Implementing Decision (EU) 2016/1190 of 19 July 2016 author ising the placing on the market of trans-resveratrol as a 
novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (OJ L 196, 21.7.2016, p. 53). 
(4)Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 Januar y 1997 concer ning novel foods and novel food 
ingredients (OJ L 43, 14.2.1997, p. 1). 
(5)Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the appro ximation of the laws of the 
Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51). EN Offi cial Jour nal of the European Union L 23/10                                                                                                                                           25.1.2021   (7) The Commission did not request an opinion from the European Food Safety Auth ority in accordance with 
Article 10(3) as the change of the conditions of use of the novel food trans-resveratrol by removing the specifi c 
deliver y formats of food supplements is not liable to have an effect on human health. Theref ore, it is appropr iate to 
change the conditions of use of the novel food trans-resveratrol to author ise its use in any form of food supplements 
at the previously author ised maximum level. 
(8) The maximum level of trans-resveratrol in food supplements author ised by Implementing Decision (EU) 2016/1190 
and indicated in the Union list of novel foods remains the same. The safety considerations that suppor ted the 
author isation of trans-resveratrol in food supplements remain valid and the remo val of the specifi c deliver y formats 
of food supplements does not pose safety concer n. 
(9) The Annex to Implementing Regulation (EU) 2017/2470 should theref ore be amended according ly. 
(10) The measures provid ed for in this Regulation are in accordance with the opinion of the Standing Committ ee on 
Plants, Animals, Food and Feed, 
HAS ADOPTED THIS REGUL ATION: 
Article 1 
1. The entr y in the Union list of author ised novel foods as provi ded for in Article 6 of Regulation (EU) 2015/2283 and 
included in Implementing Regulation (EU) 2017/2470, referring to the ‘trans-resveratrol’, shall be amended as specified in 
the Annex to this Regulation. 
2. The entr y in the Union list refer red to in paragraph 1 shall include the conditions of use and labelling requirements 
laid down in the Annex. 
Article 2 
This Regulation shall enter into force on the twentieth day followi ng that of its publication in the Official Journal of the 
European Union. 
This Regulation shall be binding in its entirety and directly applicable in all Member States. 
Done at Brussels, 22 Januar y 2021.  
For the Commission 
The President 
Ursula VON DER LEYEN     EN Offi cial Jour nal of the European Union 25.1.2021                                                                                                                                           L 23/11   ANNEX 
In the Annex to Implementing Regulation (EU) 2017/2470, the entr y for ‘Trans-resveratrol’ in Table 1 (Author ised novel foods) is replaced by the follo wing:                                                               
Authorised novel food Conditions under whic h the novel food may be used Additional specific labelling requirements Other requirements Data protection 
‘Trans-resveratrol Specified food categor y Maximum levels 1.The designation of the novel food on the labelling 
of the food supplements containing it shall be 
“Trans-resveratrol”. 
2.The labelling of food supplements containing 
trans-resveratrol shall bear a state ment that people 
using medicines should only consume the pro­
duct under medical super vision.’   Food supplements as defined 
in Directive 2002/46/EC for 
the adult population 150 mg/da y   EN Offi cial Jour nal of the European Union L 23/12                                                                                                                                           25.1.2021   